Reports

As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Contract Development and Manufacturing Organization (CDMO) Market: By Service: CMO, CRO; By CMO: API Manufacturing, Finished Product Manufacturing, Packaging; By CRO: Discovery, Preclinical, Clinical, Others; Regional Analysis; Historical Market and Forecast (2017-2027); Competitive Landscape; Industry Events and Developments

Global Contract Development and Manufacturing Organization (CDMO) Market Outlook

The global contract development and manufacturing organization market attained a value of about USD 177.1 billion in 2020. The market is further expected to grow in the forecast period of 2022-2027 at a CAGR of 8.4% to reach nearly USD 302 billion by 2026.

 

Global Contract Development and Manufacturing Organization (CDMO) Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

North America and Asia Pacific to Dominate the CDMO Market

The North American region is one of the leading market regions for contract development and manufacturing organization. This is because of the active CDMO major players in the region who are having increasing collaborations and offer diverse service features. Asia Pacific is expected to register rapid growth rate for CDMO because of the huge workforce with high skills and the lower cost advantage in the research and development and manufacturing. The government regulations and increasing emphasis on off-patent drugs have also favoured the CDMO industry in this region.

 

Contract Development and Manufacturing Organization (CDMO): Industry Definition and Segmentation

CDMO refers to the organization which is involved in serving other pharmaceutical companies in order to provide various services such as drug development and marketing. The CDMO partners with pharmaceutical firms on contractual basis to help these firms outsource the activities such as ones that can enhance their market size and clinical research.

 

Global Contract Development and Manufacturing Organization (CDMO) Market By Service

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

On the basis of service offered, the market is segmented into:

  • CMO
  • CRO

On the grounds of CMO, the industry is divided into:

  • API Manufacturing
  • Finished Product Manufacturing
    • Solid
    • Liquid
    • Injectable
  • Packaging
  • Others

On the basis of CRO, industry is classified into:

  • Clinical
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
  • Discovery
  • Preclinical
  • Laboratory Services
    • Bioanalytical Services
    • Analytical Services
  • Others

The regional markets for CDMO industry can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Global Contract Development and Manufacturing Organization (CDMO) Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

CDMO Market to be Boosted by the Increasing Demand for Pharmaceutical Products

The CDMO sector has been able to swiftly provide new and effective drugs in the market through optimizing the supply chain and enhancing the marketing capabilities of pharmaceutical companies. This is bolstering the demand for CDMO market. The rising population of the world is marked with increasing acute and chronic diseases. The disposable income of the people has grown with an increasing awareness towards healthcare. This is driving the demand for pharmaceutical products in the market which leads to rapid growth of CDMO industry. The increasing investment in research and development in drugs and manufacturing by CDMOs is accelerating the industry demand. The growth of nuclear medicines and gene therapy will further augment the demand for CDMOs.

 

Key Industry Players in the Contract Development and Manufacturing Organization Market

The report gives a detailed analysis of the following key players in the global contract development and manufacturing organization market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds: 

  • Lonza Group Ltd 
  • Catalent, Inc. 
  • Thermo Fisher Scientific, Inc. 
  • Jubilant Pharmova Ltd 
  • Aenova Holding GmbH 
  • Boehringer Ingelheim International GmbH 
  • Pfizer Inc. 
  • CordenPharma GmbH 
  • Recipharm AB 
  • Siegfried Holding AG 
  • Albany Molecular Research Inc. 
  • Fabbrica Italiana Sintetici S.p.A 
  • Fareva SA

The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model along with giving a SWOT analysis.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Service, CMO, CRO, Region
Breakup by Service CMO, CRO
Breakup by CMO API Manufacturing, Finished Product Manufacturing, Packaging, Others
Breakup by CRO Discovery, Preclinical, Clinical, Laboratory Services, Others
Breakup by Region North America, Latin America, Europe, Middle East and Africa, Asia Pacific
Market Dynamics SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Lonza Group Ltd, Catalent, Inc., Thermo Fisher Scientific, Inc., Jubilant
Pharmova Ltd, Aenova Holding GmbH, Boehringer Ingelheim International GmbH,
Pfizer Inc., CordenPharma GmbH, Recipharm AB, Siegfried Holding AG,
Albany Molecular Research Inc., Fabbrica Italiana Sintetici S.p.A, Fareva SA
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Contract Development and Manufacturing Organization (CDMO) Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Contract Development and Manufacturing Organization (CDMO) Historical Market (2017-2021) 
    8.3    Global Contract Development and Manufacturing Organization (CDMO) Market Forecast (2022-2027)
    8.4    Global Contract Development and Manufacturing Organization (CDMO) Market by Service
        8.4.1    CMO
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
        8.4.2    CRO
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027)
    8.5    Global Contract Development and Manufacturing Organization (CDMO) Market by CMO
        8.5.1    API Manufacturing
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2017-2021)
            8.5.1.3    Forecast Trend (2022-2027)
        8.5.2    Finished Product Manufacturing
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2017-2021)
            8.5.2.3    Forecast Trend (2022-2027)
            8.5.2.4    Breakup by Type
                8.5.2.4.1    Solid
                8.5.2.4.2    Liquid
                8.5.2.4.3    Injectable
        8.5.3    Packaging
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2017-2021)
            8.5.3.3    Forecast Trend (2022-2027)
        8.5.4    Others
    8.6    Global Contract Development and Manufacturing Organization (CDMO) Market by CRO
        8.6.1    Discovery
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2017-2021)
            8.6.1.3    Forecast Trend (2022-2027)
        8.6.2    Preclinical
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2017-2021)
            8.6.2.3    Forecast Trend (2022-2027)
        8.6.3    Clinical
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2017-2021)
            8.6.3.3    Forecast Trend (2022-2027)
            8.6.3.4    Breakup by Type
                8.6.3.4.1    Phase I
                8.6.3.4.2    Phase II
                8.6.3.4.3    Phase III
                8.6.3.4.4    Phase IV
        8.6.4    Laboratory Services
            8.6.4.1    Market Share
            8.6.4.2    Historical Trend (2017-2021)
            8.6.4.3    Forecast Trend (2022-2027)
            8.6.4.4    Breakup by Type
                8.6.4.4.1    Bioanalytical Services
                8.6.4.4.2    Analytical Services
        8.6.5    Others
    8.7    Global Contract Development and Manufacturing Organization (CDMO) Market by Region
        8.7.1    Market Share
            8.7.1.1    North America
            8.7.1.2    Europe
            8.7.1.3    Asia Pacific
            8.7.1.4    Latin America
            8.7.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2017-2021)
        9.1.2    Forecast Trend (2022-2027)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2017-2021)
        9.2.2    Forecast Trend (2022-2027)
        9.2.3    Breakup by Country
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2017-2021)
        9.3.2    Forecast Trend (2022-2027)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2017-2021)
        9.4.2    Forecast Trend (2022-2027)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2017-2021)
        9.5.2    Forecast Trend (2022-2027)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    Lonza Group Ltd
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    Catalent, Inc.
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3    Thermo Fisher Scientific, Inc.
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    Jubilant Pharmova Ltd
            12.2.4.1    Company Overview
            12.2.4.2    Product Portfolio
            12.2.4.3    Demographic Reach and Achievements
            12.2.4.4    Certifications
        12.2.5    Aenova Holding GmbH 
            12.2.5.1    Company Overview
            12.2.5.2    Product Portfolio
            12.2.5.3    Demographic Reach and Achievements
            12.2.5.4    Certifications
        12.2.6    Boehringer Ingelheim International GmbH
            12.2.6.1    Company Overview
            12.2.6.2    Product Portfolio
            12.2.6.3    Demographic Reach and Achievements
            12.2.6.4    Certifications
        12.2.7    Pfizer Inc.
            12.2.7.1    Company Overview
            12.2.7.2    Product Portfolio
            12.2.7.3    Demographic Reach and Achievements
            12.2.7.4    Certifications
        12.2.8    CordenPharma GmbH
            12.2.8.1    Company Overview
            12.2.8.2    Product Portfolio
            12.2.8.3    Demographic Reach and Achievements
            12.2.8.4    Certifications
        12.2.9    Recipharm AB
            12.2.9.1    Company Overview
            12.2.9.2    Product Portfolio
            12.2.9.3    Demographic Reach and Achievements
            12.2.9.4    Certifications
        12.2.10    Siegfried Holding AG
            12.2.10.1    Company Overview
            12.2.10.2    Product Portfolio
            12.2.10.3    Demographic Reach and Achievements
            12.2.10.4    Certifications
        12.2.11    Albany Molecular Research Inc.
            12.2.11.1    Company Overview
            12.2.11.2    Product Portfolio
            12.2.11.3    Demographic Reach and Achievements
            12.2.11.4    Certifications
        12.2.12    Fabbrica Italiana Sintetici S.p.A
            12.2.12.1    Company Overview
            12.2.12.2    Product Portfolio
            12.2.12.3    Demographic Reach and Achievements
            12.2.12.4    Certifications
        12.2.13    Fareva SA
            12.2.13.1    Company Overview
            12.2.13.2    Product Portfolio
            12.2.13.3    Demographic Reach and Achievements
            12.2.13.4    Certifications
13    Industry Events and Developments


List of Figures and Tables

1.    Global Contract Development and Manufacturing Organization (CDMO) Market: Key Industry Highlights, 2016 and 2026
2.    Global Contract Development and Manufacturing Organization (CDMO) Historical Market: Breakup by Service (USD Billion), 2017-2021
3.    Global Contract Development and Manufacturing Organization (CDMO) Market Forecast: Breakup by Service (USD Billion), 2022-2027
4.    Global Contract Development and Manufacturing Organization (CDMO) Historical Market: Breakup by CMO (USD Billion), 2017-2021
5.    Global Contract Development and Manufacturing Organization (CDMO) Market Forecast: Breakup by CMO (USD Billion), 2022-2027
6.    Global Contract Development and Manufacturing Organization (CDMO) Historical Market: Breakup by CRO (USD Billion), 2017-2021
7.    Global Contract Development and Manufacturing Organization (CDMO) Market Forecast: Breakup by CRO (USD Billion), 2022-2027
8.    Global Contract Development and Manufacturing Organization (CDMO) Historical Market: Breakup by Region (USD Billion), 2017-2021
9.    Global Contract Development and Manufacturing Organization (CDMO) Market Forecast: Breakup by Region (USD Billion), 2022-2027
10.    North America Contract Development and Manufacturing Organization (CDMO) Historical Market: Breakup by Country (USD Billion), 2017-2021
11.    North America Contract Development and Manufacturing Organization (CDMO) Market Forecast: Breakup by Country (USD Billion), 2022-2027
12.    Europe Contract Development and Manufacturing Organization (CDMO) Historical Market: Breakup by Country (USD Billion), 2017-2021
13.    Europe Contract Development and Manufacturing Organization (CDMO) Market Forecast: Breakup by Country (USD Billion), 2022-2027
14.    Asia Pacific Contract Development and Manufacturing Organization (CDMO) Historical Market: Breakup by Country (USD Billion), 2017-2021
15.    Asia Pacific Contract Development and Manufacturing Organization (CDMO) Market Forecast: Breakup by Country (USD Billion), 2022-2027
16.    Latin America Contract Development and Manufacturing Organization (CDMO) Historical Market: Breakup by Country (USD Billion), 2017-2021
17.    Latin America Contract Development and Manufacturing Organization (CDMO) Market Forecast: Breakup by Country (USD Billion), 2022-2027
18.    Middle East and Africa Contract Development and Manufacturing Organization (CDMO) Historical Market: Breakup by Country (USD Billion), 2017-2021
19.    Middle East and Africa Contract Development and Manufacturing Organization (CDMO) Market Forecast: Breakup by Country (USD Billion), 2022-2027
20.    Global Contract Development and Manufacturing Organization (CDMO) Market Structure

Key Questions Answered in the Report

In 2020, the global contract development and manufacturing organisation (CDMO) market attained a value of nearly USD 177.1 billion.

The market is projected to grow at a CAGR of 8.4% between 2021 and 2026.

The market is estimated to witness healthy growth in the forecast period of 2022-2027 to reach USD 302 billion by 2026.

The major drivers of the market include the disposable income of the people and the swift provision of new and effective drugs in the market through optimising the supply chain and enhancing the marketing capabilities of pharmaceutical companies.

The contract development and manufacturing organisation (CDMO) market is being aided by disposable income of the people.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

CMO and CRO are the leading services in the industry.

API manufacturing, finished product manufacturing, and packaging, among others are the leading CMO in the industry.

Clinical, discovery, preclinical, and laboratory services, among others are the leading CRO in the industry.

The major players in the industry are Lonza Group Ltd, Catalent, Inc., Thermo Fisher Scientific, Inc., Jubilant Pharmova Ltd, Aenova Holding GmbH, Boehringer Ingelheim International GmbH, Pfizer Inc., CordenPharma GmbH, Recipharm AB, Siegfried Holding AG, Albany Molecular Research Inc., Fabbrica Italiana Sintetici S.p.A, and Fareva SA.

Analyst Review

The global contract development and manufacturing organization (CDMO) market attained a value of USD 177.1 billion in 2020, driven by the swift provision of new and effective drugs in the market through optimizing the supply chain and enhancing the marketing capabilities of pharmaceutical companies. The market is expected to witness further growth in the forecast period of 2022-2027, growing at a CAGR of 8.4%. The market is projected to reach USD 302 billion by 2026.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its services, the contract development and manufacturing organization (CDMO) industry can be segmented into CMO and CRO. On the basis of CMO, the market is divided into API manufacturing, finished product manufacturing, and packaging, among others. Based on CRO, the market is divided into clinical, discovery, preclinical, and laboratory services, among others. The major regional markets for contract development and manufacturing organization (CDMO) are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Lonza Group Ltd, Catalent, Inc., Thermo Fisher Scientific, Inc., Jubilant Pharmova Ltd, Aenova Holding GmbH, Boehringer Ingelheim International GmbH, Pfizer Inc., CordenPharma GmbH, Recipharm AB, Siegfried Holding AG, Albany Molecular Research Inc., Fabbrica Italiana Sintetici S.p.A, and Fareva SA.Catalent, Inc, Boehringer Ingelheim International GmbH, Recipharm AB, Albany Molecular Research Inc., Pfizer Inc and Jubilant Life Sciences Ltd among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER